Latest News and Press Releases

Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "Hedgehog Pathway Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...

Presentations will be delivered by experts from a wide variety of leading research groups including Pfizer, GSK, and Bio-Techne, along with co-hosts IPA, ACROBiosystems, and Curia. SALT LAKE CITY,...

Dr. Rietiker has considerable experience in the life sciences industry, including leadership positions in global pharmaceutical and medical device companies, and has overseen multiple major company...

Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Innovation Insights: Target validation for genetic targets" report has been added to ResearchAndMarkets.com's offering. In terms of deals related...

Dublin, April 15, 2025 (GLOBE NEWSWIRE) -- The "Central Lab Services/Clinical Trial Lab Services Market by Phase (Phase I, II, III), Service Type (Safety Testing, Immunology), Therapeutic Area...

The U.S. Phase 2 trial aims to evaluate efficacy and safety of CX11 in doses up to 200 mg and different titration schemesThe trial is expected to enroll 250 patients to receive treatment over 36 weeks...

Kyiv, Ukraine and Salt Lake City, UT, April 09, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today...

Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Drug Discovery Services Market by Process (Target Validation, Hit-to-Lead, Lead Optimization), Type (Chemistry, Biology), Therapeutic Area (Oncology,...

Dublin, April 02, 2025 (GLOBE NEWSWIRE) -- The "STAT3 Inhibitors Market Opportunity & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. The market for...

Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Immunotherapy in Oncology Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The...